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Spermidine (SPD) is an endogenous polyamine that modulates N-methyl-D-aspartate (NMDA) receptor
function, and has been reported to facilitate memory formation. In the current study we determined
whether or not the PKA/CREB signaling pathway is involved in SPD-induced facilitation of memory of
inhibitory avoidance task in adult rats. The post-training administration of the cAMP-dependent protein
kinase (PKA) inhibitor, N-[2-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide [H-89, 0.5 qmol
intrahippocampal (ih)] or the antagonist of the NMDA receptor polyamine-binding site (arcaine,
0.02 nmol ih) with SPD (0.2 nmol ih) prevented memory improvement induced by SPD. Intrahippocampal
administration of SPD (0.2 nmol) facilitated PKA and cAMP response element-binding protein (CREB)
phosphorylation in the hippocampus 180 min, but not 30 min, after administration, and increased trans-
location of the catalytic subunit of PKA into the nucleus. Arcaine (0.02 nmol) and H-89 (0.5 qmol) pre-
vented the stimulatory effect of SPD on PKA and CREB phosphorylation. These results suggest that
memory enhancement induced by the ih administration of SPD involves the PKA/CREB pathways in rats.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The polyamines putrescine, spermine, and spermidine (SPD) are
a group of aliphatic amines that are present at high concentrations
in cerebral structures involved in learning and memory (Carter,
1994). Polyamine concentrations change with age (Liu, Gupta, Jing,
& Zhang, 2008), and it has been suggested that region-speciﬁc
changes in polyamine levels may be causally related to age-associ-
ated memory impairment.
Polyamines modulate learning and memory by interacting with
the polyamine-binding site at the N-methyl-D-aspartate receptor
(NMDAr) (Izquierdo & Medina, 1997; Kishi, Ohno, & Watanabe,
1998a, 1998b; Rubin et al., 2000; Rubin et al., 2001; Rubin et al.,
2004; Shimada, Spangler, London, & Ingram, 1994). Accordingly,
the systemic (Camera, Mello, Ceretta, & Rubin, 2007), intrahippo-
campal (ih) (Berlese et al., 2005; Gomes et al., 2010; Guerra
et al., 2006; Rubin et al., 2000), and intra-amygdalar (Rubin et al.,
2001; Rubin et al., 2004) administration of SPD improves memory.
While there is evidence that NMDAr activation is involved in the
facilitation of memory induced by SPD (Guerra et al., 2006), thebin).
sevier OA license.role of downstream kinases in SPD-induced memory improvement
has not been deﬁned. This is particularly relevant considering that
NMDAr-associated intracellular signaling results in the activation
of multiple protein targets, such as PKA (Bernabeu et al., 1997a;
Bevilaqua et al., 1997; Chetkovich, Gray, Johnston, & Sweatt,
1991; Chetkovich & Sweatt, 1993; Eliot, Dudai, Kandel, & Abrams,
1989), protein kinase C (PKC) (Bernabeu, Cammarota, Izquierdo,
& Medina, 1997b; Bernabeu, Izquierdo, Cammarota, Jerusalinsky,
& Medina, 1995), calcium–calmodulin-dependent protein kinase
II (CaMKII) (Bernabeu et al., 1997b; Giese, Fedorov, Filipkowski, &
Silva, 1998; Mayford, Abel, & Kandel, 1995a; Silva, Stevens, Toneg-
awa, & Wang, 1992; Wolfman et al., 1994), and protein kinase G
(PKG) (Bernabeu et al., 1997c).
The cAMP/PKA signaling pathway seems to play a role in the
ﬁnal phases of memory consolidation, which require protein
synthesis (Abel et al., 1997; Barad, Bourtchouladze, Winder, Golan,
& Kandel, 1998; Bernabeu et al., 1997a; Huang & Kandel, 1998;
Pereira, Ardenghi, Mello e Souza, Medina, & Izquierdo, 2001;
Quevedo et al., 2005; Vianna et al., 2000). There are lines of evi-
dence supporting a role for adenosine 30,50 monophosphate (cAMP)
in learning and memory. First, hippocampal cAMP levels slowly
increase beginning 60 min after inhibitory avoidance training,
reaching a peak 180–360 min after training (Bernabeu, Schmitz,
Faillace, Izquierdo, & Medina, 1996; Bernabeu et al., 1997a, 1997b).
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such as a phosphodiesterase inhibitor (Puzzo et al., 2009; Vitolo
et al., 2002; Zhang, Crissman, Dorairaj, Chandler, & O’Donnell,
2000; Zhang et al., 2004) a cAMP analog, an adenylyl cyclase activa-
tor (Bernabeu et al., 1997a), and the overexpression of type I aden-
ylyl cyclase (Wang, Ferguson, Pineda, Cundiff, & Storm, 2004),
facilitates memory formation. Third, mice lacking type I adenylyl
cyclase present diminished cAMP levels and memory formation
deﬁcits in different tasks (Wong et al., 1999; Wu et al., 1995).
The PKA family consists of four regulatory (R) subunits (RIa, RIb,
RIIa, and RIIb) and three catalytic (C) subunits (Ca, Cb, and Cc)
(Doskeland, Maronde, & Gjertsen, 1993; McKnight et al., 1988),
which are expressed in mammalian brain (Cadd & McKnight,
1989). Each R subunit contains two binding sites for cAMP (Taylor,
Buechler, & Yonemoto, 1990), which activate PKA (Gibbs, Knighton,
Sowadski, Taylor, & Zoller, 1992; Taylor et al., 1990). PKA activity
increases after inhibitory avoidance training in the following two
peaks: the ﬁrst, that occurs immediately after training; and the
second peak, that occurs 3–6 h later, and correlates with the max-
imum rise of cAMP levels after training (Bernabeu et al., 1997a).
A role for PKA in memory has been supported by the ﬁndings
that speciﬁc inhibitors impair memory (Ahi, Radulovic, & Spiess,
2004; Bernabeu et al., 1997a; Bourtchouladze et al., 1998; Quevedo
et al., 2004; Sharifzadeh, Sharifzadeh, Naghdi, Ghahremani, &
Roghani, 2005; Vianna et al., 2000; Wallenstein, Vago, & Walberer,
2002) and that R (AB) transgenic mice, which express an inhibitory
form of the regulatory subunit of PKA, exhibit memory deﬁcits
(Abel et al., 1997; Bourtchouladze et al., 1998; Isiegas, Park, Kandel,
Abel, & Lattal, 2006).
CREB is a transcription factor whose phosphorylation on Ser133
by PKA causes its activation (Bernabeu et al., 1997a; Gonzalez &
Montminy, 1989). Phosphorylated CREB (p-CREB) levels in the hip-
pocampus increase after inhibitory avoidance training in two peaks
that correlate with the peaks of increased PKA activity (Bernabeu
et al., 1997a,b). The coincident increase in the nuclear phosphory-
lated form of CREB at these speciﬁc periods, together with memory
sensitivity to inhibitors of gene transcription and protein synthesis
during PKA active periods, suggest that this signaling pathway may
contribute to the synthesis of new proteins, a crucial event for
long-term memory establishment. Therefore, in the current study
we investigated whether PKA/CREB signaling pathways are acti-
vated by SPD in rats subjected to inhibitory avoidance training.2. Materials and methods
2.1. Animals
All animal experiments reported in this study were conducted
in accordance with Brazilian law No. 11.794/2008 in agreement
with the Policies on the Use of Animals and Humans in Neurosci-
ence Research, which were revised and approved by the Society
for Neuroscience Research in January 1995, and with the Institu-
tional and National Regulations for Animal Research (process
0206). Male Wistar rats (230–250 g; n = 222) were bred in the
Animal House of the Federal University of Santa Maria, housed 5
to a cage, and maintained on a natural day/night cycle at a temper-
ature of 21 C with access to water and rodent laboratory chow
(Guabi, Santa Maria, RS, Brazil) ad libitum. Behavioral tests were
conducted during the light phase of the cycle (between 9:00 AM
and 5:00 PM).2.2. Surgery
Rats were anaesthetized by intraperitoneal (ip) injection of a
mixture of ketamine (80 mg/kg) and xylazine (8 mg/kg), and wereimplanted with two 27-gauge guide cannulae placed 1 mm above
the CA1 region of the dorsal hippocampus at the following coordi-
nates: A, 4 mm; L, 3.0 mm; and V, 2.0 mm (Paxinos & Watson,
1986). Placement of injections was histologically-veriﬁed, as de-
scribed elsewhere (Rubin et al., 1997). Only data from the animals
with correct cannula placement were analyzed.
2.3. Behavioral and infusion procedures
One week after surgery, the animals were subjected to a single
training session in a step-down inhibitory avoidance apparatus,
consisting of a 25  25  35-cm box with a grid ﬂoor and the left
portion covered by a 7  25-cm platform, measuring 2.5 cm in
height. The rat was placed gently on the platform facing the rear
left corner. Once the rat stepped down with all 4 paws on the grid,
a 3-s, 0.3-mA shock was applied to the grid. Immediately post-
training, vehicle, one drug, or a combination of the following drugs
were injected bilaterally into the hippocampus (0.5 ll/brain hemi-
sphere over 1 min): spermidine [N-(3-aminopropyl)-1,4-butanedi-
amine trihydrochloride (SPD); Sigma–Aldrich Co., St. Louis, MO,
USA]; arcaine (1,4-diguanidinobutane sulfate; Sigma–Aldrich
Co.); and N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulf-
onamide dihydrochloride (H-89; Sigma–Aldrich Co.). H-89 is an
isoquinolinesulfonamide which inhibits PKA by competing with
ATP for the catalytic subunit of enzyme (Chijiwa et al., 1990;
Hidaka, Hagiwara, & Chijiwa, 1990). SPD and arcaine were dis-
solved in 50 mM phosphate buffer saline (PBS; pH 7.4), and H-89
was dissolved in 0.01% DMSO in 50 mM PBS (pH 7.4). The injec-
tions were performed via an infusion pump using a 30-gauge
needle ﬁtted into the guide cannula. The tip of the infusion needle
protruded 1.0 mm beyond that of the guide cannula into the CA1
region in the dorsal hippocampus. The injection needles were left
in place for an additional 60 s to minimize backﬂow. After the
injection, the animals were returned to their home cages and
tested for retention 24 h later. A step-down latency test was taken
as a measure of retention, with a cut-off time of 600 s.
Immediately after the inhibitory avoidance test session, the ani-
mals were transferred to a 50  60-cm open ﬁeld, with the ﬂoor
divided into 12 squares. During the 5-min open ﬁeld session, the
number of crossing and rearing responses was recorded. The open
ﬁeld was used to identify motor disabilities which might inﬂuence
inhibitory testing avoidance performance.
Step-down latency data were analyzed with the Kruskal–Wallis
test or the Scheirer–Ray–Hare extension of the Kruskal–Wallis test.
Crossing and rearing responses were analyzed by one- or two-way
ANOVA. Signiﬁcance was considered at a p < 0.05.
2.4. Preparation of tissues and Western blot analysis
Western blot analysis was carried out, as described previously
(Casu et al., 2007) with minor modiﬁcations. Rats were decapi-
tated, and the hippocampi were rapidly removed, dissected,
homogenized in 300 ll of ice-cold A buffer (10 mM KCl, 2 mM
MgCl2, 1 mM EDTA, 1 mM NaF, 10 lg/ml aprotinin, 10 mM
b-glycerolphosphate, 1 mM PMSF, 1 mM DTT, and 2 mM of sodium
orthovanadate in 10 mM HEPES, pH 7.9), incubated for 15 min on
ice, and centrifuged at 16 000g for 45 min at 4 C. The superna-
tant (S1), denominated cytosolic fraction, was reserved for poster-
ior processing. The pellet (P1) was resuspended in 150 ll of ice-
cold buffer B (10 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM NaF,
10 lg/ml aprotinin, 10 mM b-glycerolphosphate, 1 mM PMSF,
1 mM DTT, 2 mM sodium orthovanadate, and 1% Triton-X in
10 mM HEPES, pH 7.9), incubated for 15 min on ice, and centri-
fuged at 16 000g for 45 min at 4 C. The supernatant (S2) was dis-
carded and the pellet (P2) was resuspended in 100 ll of ice-cold
buffer C (50 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM NaF,
Table 1
Effect of the post-training intrahippocampal administration of H-89 (0.5–5 qmol) on
the inhibitory avoidance task performance of rats (measured as the test step-down
latency) and on the behavior of rats (number of crossing and rearing responses) in the
open ﬁeld immediately after the inhibitory avoidance testing session.
Group Latency (s) Crossing Rearing N
PBS 129.0 (51.5–355.5) 15.6 ± 1.3 6.7 ± 0.7 13
H-89 (0.5 qmol) 91.0 (63.5–382.5) 15.5 ± 2.0 7.0 ± 1.6 13
H-89 (5 qmol) 41.0 (20–102.5) 15.7 ± 1.6 6.6 ± 0.9 13
Statistical analysis H2 = 6.72, p < 0.05 F2,36 = 0.005,
p > 0.05
F2,36 = 0.042,
p > 0.05
Data are the median (interquartile ranges) or means ± SEM; N, number of animals in
each group.
Fig. 1. Co-administration of H-89 (0.5 qmol intrahippocampus) immediately after
training prevents the improvement in memory induced by spermidine (SPD,
0.2 nmol). Phosphate-buffered saline (50 mM PBS, pH 7.4) was used as a vehicle.
Data are the median and interquartile range for 16 animals in each group. ⁄P<0.05 as
compared with control group values (PBS/PBS).
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1 mM DTT, 2 mM sodium orthovanadate, 420 mM NaCl, and 25%
glycerol in 20 mM HEPES, pH 7.9), incubated for 15 min on ice,
and centrifuged at 16,000g for 45 min at 4 C. The supernatant
(S3) was considered the nuclear fraction (Medeiros et al., 2007).
The protein concentration in the cytosolic and nuclear fractions
was determined using the Bradford method (1976). Equivalent
amounts of protein (80 lg or 20 lg for cytosolic or nuclear frac-
tions, respectively) were added to 0.2 volumes of concentrated
loading buffer (200 mM Tris, 10% glycerol, 2% SDS, 2.75 mM
b-mercaptoethanol, and 0.04% bromophenol blue) and boiled for
10 min. Proteins were separated in 12% sodium dodecyl sulfate–
polyacrylamide gels (SDS–PAGE) and transferred to polyvinilidene
diﬂuoride membranes. Ponceau staining (data not shown) served
as a loading control (Romero-Calvo et al., 2010). Western blot anal-
ysis of PKA regulatory subunit and CREB was carried out in the
cytosolic and nuclear fractions, respectively. PKA catalytic subunit
immunoreactivity was measured in the nuclear and cytosolic frac-
tions, in order to determine whether PKA catalytic subunit translo-
cated to the nucleus, as described below. Membranes were
processed using a SNAP i.d. system (Millipore, Billerica, MA,
USA). First, the membrane was blocked with 1% BSA in 0.05%
Tween 20 in Tris-borate saline (TBS-T), then incubated for 10 min
with speciﬁc primary antibodies diluted 1:150 in TBS-T (anti-phos-
pho-PKA RIIa, anti-total-PKA RIIa, anti-phospho-CREB-1, anti-
total-CREB-1 and anti-phospho-PKA Ca/b/c polyclonal antibodies;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Blots were
washed three times, with TBS-T followed by incubation with ad-
justed alkaline phosphatase-coupled secondary antibody (1:3000,
anti-rabbit IgG; Santa Cruz Biotechnology, Inc.) for 10 min. Protein
bands were visualized with 5-bromo-4-chloro-3-indolyl phos-
phate and p-nitro blue tetrazolium (BCIP/NBT; Millipore). Mem-
branes were dried, scanned, and quantiﬁed with the Scion Image
PC version of NIH image. The results were normalized for the con-
trol group (PBS/PBS) densitometry values and expressed as the rel-
ative amount of phosphorylated and non-phosphorylated forms,
and the phosphorylated/total ratio. Statistical analyses were per-
formed using a two-way ANOVA or a Student’s T-test. F and p val-
ues are shown only if p < 0.05.
2.5. Experiment 1 – Effect of a PKA inhibitor (H-89) on inhibitory
avoidance task performance
A dose–response curve for H-89 was performed to deﬁne the ih
dose of H-89 for the subsequent experiments. Immediately post-
training, the animals were injected with vehicle (0.01% DMSO in
50 mM PBS, pH 7.4) or H-89 (0.5–5 qmol/hippocampus). Initial
dose range was selected based on previous studies (Sharifzadeh
et al., 2006). The animals were subjected to a step-down inhibitory
avoidance session, open ﬁeld test, and histologic examination, as
described above.
2.6. Experiment 2 – Effect of a PKA inhibitor on memory improvement
and phosphorylation of the PKA and CREB induced by SPD
Once it was determined that H-89 at a dose of 0.5 qmol (ih) did
not alter memory, the effect of H-89 on SPD-induced improvement
of memory and phosphorylation of PKA and CREB were
determined. Animals were trained in the step-down inhibitory
avoidance apparatus and injected immediately post-training with
vehicle (0.01% DMSO in 50 mM PBS, pH 7.4), H-89 (0.5 qmol/
hippocampus), SPD (0.2 nmol/hippocampus), or H-89 (0.5 qmol/
hippocampus) combined with SPD (0.2 nmol/hippocampus). The
dose of SPD (0.2 nmol/hippocampus) was selected because it
improves memory of the inhibitory avoidance task (Rubin et al.,
2000). A subset of the animals was sacriﬁced 30 and 180 min afterinjections and the hippocampi were dissected for Western blot
analysis of PKA and CREB. The other animals had a testing session
in the inhibitory avoidance apparatus and an open ﬁeld test. It has
been reported previously that autophosphorylation of the PKA reg-
ulatory subunit occurs when PKA is activated by cAMP (Tasken &
Aandahl, 2004). Thus, the detection of phosphorylation of the
PKA regulatory subunit is useful evidence for PKA activation.
2.7. Experiment 3 – Effect of arcaine on memory improvement and
phosphorylation of PKA and CREB induced by SPD
Animals were trained in a step-down inhibitory avoidance
apparatus and injected immediately post-training with vehicle
(50 mM PBS, pH 7.4), arcaine (0.02 nmol/hippocampus), SPD
(0.2 nmol/hippocampus) or arcaine (0.02 nmol/hippocampus)
combined with SPD (0.2 nmol/hippocampus). The dose of arcaine
(0.02 nmol/hippocampus) did not alter memory (Rubin et al.,
2000). A subset of the animals was sacriﬁced 180 min after injec-
tion and the hippocampi were dissected for Western blot analysis
of phosphorylated forms of PKA and CREB. The other animals had a
testing session in the inhibitory avoidance apparatus and an open
ﬁeld test, as described above.
2.8. Experiment 4 – Effect of SPD on PKA catalytic subunit
translocation
Animals were trained in the step-down inhibitory avoidance
apparatus and injected immediately post-training with vehicle
(50 mM PBS, pH 7.4) or SPD (0.2 nmol/hippocampus). Three hours
after the injection, the animals were sacriﬁced and the hippocampi
were dissected for Western blot analysis of translocation of the
PKA catalytic subunit (PKA C) to the nucleus.
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3.1. Experiment 1
Table 1 shows the effect of bilateral ih injection of H-89
(0.5–5 qmol) immediately after training on test step-down laten-
cies. Statistical analysis (Kruskal–Wallis test) revealed that H-89,
in the dose of 5 qmol, signiﬁcantly decreased step-down latencies
at testing (F values shown in Table 1), revealing that injection of
the selective PKA inhibitor impaired the memory in the inhibitory
avoidance task. Table 1 also shows the effect of H-89 on explor-
atory behavior in the open ﬁeld immediately after the inhibitory
avoidance testing session. Statistical analysis of open-ﬁeld data
(one-way ANOVA) revealed that H-89 injection did not alter the
number of crossing or rearing responses in a subsequent open-ﬁeld
testing session (F values shown in Table 1), suggesting that itsFig. 2. Effect of the post-training intrahippocampal co-administration of H-89 (0.5 q
immunoblotting and densitometry analyses of phospho-PKA (A, D), total-PKA (B, E), and t
killed 30 and 180 min after the injections of H-89 and SPD, respectively. The results wer
Ponceau staining served as a loading control. Data are the mean ± SEM for 3–4 animalsinjection, immediately after training, did not cause gross motor
disabilities during testing. The dose of H-89 to be used in the
subsequent experiments (0.5 qmol) was chosen based on the lack
of effect on memory in this experiment.3.2. Experiment 2
Figs. 1–3 show the effect of the ih administration of H-89
(0.5 qmol), SPD (0.2 nmol), and the co-administration of H-89
and SPD immediately after training on step-down latencies during
testing (Fig. 1) and on Western immunoblotting and densitometry
analyses of PKA (Fig. 2) and CREB phosphorylation (Fig. 3). Statisti-
cal analysis of step-down latencies during testing (nonparametric
two-way ANOVA) showed a signiﬁcant SPD or PBS vs H-89 or
PBS interaction [H1 = 6.84, p < 0.05], revealing that co-injection of
the selective PKA inhibitor prevented facilitation of memorymol) and spermidine (SPD, 0.2 nmol) on the representative images of Western
he ratio of phospho- PKA/total-PKA (C, F). In Fig. A, B, and C, and D, E, and F rats were
e normalized by arbitrarily setting the densitometry of the control group (PBS/PBS).
in each group. ⁄P < 0.05 as compared with control group values (PBS/PBS).
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ment induced by SPD depends on PKA activation. The open ﬁeld
data demonstrated that pharmacologic treatment did not alter
the number of crossing or rearing responses in a subsequent open
ﬁeld testing session (data not shown). These data indicate that
none of the compounds tested caused gross motor disabilities
during testing.
Statistical analysis (two-way ANOVA) also revealed that bilat-
eral hippocampal injection of H-89, SPD, or a combination of
H-89 and SPD did not alter phospho-PKA immunoreactivity at 30
or 180 min (Fig. 2A and D). However, a signiﬁcant SPD or PBS ver-
sus H-89 or PBS interaction for total PKA levels [F1,11 = 7.60,
p < 0.05, Fig. 2E] and the phospho-PKA/total PKA ratio at 180 min
[F1,11 = 8.82, p < 0.05, Fig. 2F], but not 30 min (Fig. 2B and C) after
the injections. These results suggest that H-89 prevents the SPD-
induced increase in the phospho-PKA/total PKA ratio and decrease
in the total PKA level. The administration of H-89, SPD, or a combi-Fig. 3. Effect of the intrahippocampal co-administration of H-89 (0.5 qmol) and spermid
phospho-CREB/total-CREB ratio (C, F). A, B, and C, and D, E, and F show the 30- and 1
densitometry of the control group (PBS/PBS). Ponceau staining served as a loading control
control group values (PBS/PBS).nation of H-89 and SPD did not alter the total CREB levels (Fig. 3B
and E) at 30 and 180 min; however, a signiﬁcant SPD or PBS versus
H-89 or PBS interaction for phospho-CREB levels [F1,12 = 11.54,
p < 0.05, Fig. 3D] and the phospho-CREB/total-CREB ratio at
180 min [F1,12 = 13.78, p < 0.05, Fig. 3F], but not at 30 min (Fig. 3A
and C) after injections was found, indicating that H-89 prevented
the SPD-induced increase of the phospho-CREB level and phos-
pho-CREB/total-CREB ratio.
3.3. Experiment 3
Figs. 4–6 show the effect of the ih administration of arcaine
(0.02 nmol), SPD (0.2 nmol), and the co-administration immedi-
ately after training on step-down latencies during testing and on
Western immunoblotting and densitometry analyses of PKA and
CREB phosphorylation. Step-down latencies had a signiﬁcant PBS
or SPD versus PBS or arcaine interaction [H1 = 5.08; p < 0.05],ine (SPD, 0.2 nmol) on the levels of phospho-CREB (A, D), total-CREB (B, E), and the
80-min data, respectively. The results were normalized by arbitrarily setting the
. Data are the mean ± SEM for 3–4 animals in each group. ⁄P < 0.05 as compared with
Fig. 4. Co-administration of arcaine (ARC, 0.02 nmol, ih) immediately after training
prevents the improvement in memory induced by spermidine (0.2 nmol). Phos-
phate-buffered saline (50 mM PBS, pH 7.4) was used as a vehicle. Data are the
median ± interquartile ranges for 14 animals in each group. ⁄P < 0.05 as compared
with control group values (PBS/PBS).
Fig. 5. Effect of the post-training intrahippocampal co-administration of arcaine
(ARC, 0.02 nmol) and spermidine (SPD, 0.2 nmol) on representative images of
Western immunoblotting and densitometry analyses of phospho-PKA (A), total-PKA
(B), and the ratio of phospho-PKA/total-PKA (C) 180 min after the injection of SPD
and ARC. The results were normalized by arbitrarily setting the densitometry of the
control group (PBS/PBS). Ponceau staining served as a loading control. Data are the
mean ± SEM for four animals in each group. ⁄P < 0.05 as compared with control
group values (PBS/PBS).
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binding site at the NMDA receptor prevents the facilitation of
memory induced by SPD (Fig. 4). The open ﬁeld data demonstrated
that pharmacologic treatment did not alter the number of crossing
or rearing responses in a subsequent open ﬁeld testing session
(data not shown), indicating that the tested compounds do not
cause gross motor disabilities during testing.
Arcaine, SPD, or a combination of arcaine and SPD did not signif-
icantly modify the phospho-PKA and total-PKA levels (Fig. 5A and
B); however, we showed a signiﬁcant polyamine (PBS or SPD) ver-
sus NMDA antagonist (PBS or arcaine) interaction [F1,12 = 7.03,
p < 0.05] for the phospho-PKA/total-PKA ratio (Fig. 5C). This result
suggests that arcaine prevents the SPD-induced increase in the
phospho-PKA/total-PKA ratio.
The administration of arcaine, SPD, or a combination of arcaine
and SPD did not signiﬁcantly alter the total-CREB levels (Fig. 6B).
However, we found a signiﬁcant SPD or PBS versus arcaine or
PBS interaction for the phospho-CREB levels [F1,12 = 4.85, p < 0.05,
Fig. 6A] and the ratio of phospho-CREB/total-CREB [F1,12 = 5.34,
p < 0.05, Fig. 6C]. This data suggests that arcaine prevents the
SPD-induced increase in phospho-CREB levels and the ratio of
phospho-CREB/total-CREB, and that the PKA/CREB pathway under-
lies the facilitatory effects of SPD on memory.
3.4. Experiment 4
Fig. 7 shows the effect of ih administration of SPD (0.2 nmol)
immediately after training on immunocontent of phospho-PKA
catalytic subunits to cytosolic and nuclear fraction SPD did not sig-
niﬁcantly modify the catalytic subunits of phospho-PKA levels in
the cytosolic fraction (Fig. 7A); however, SPD increased the cata-
lytic subunits of phospho-PKA levels in the nucleus fraction
(t = 1.926, df = 14, p < 0.05, Fig. 7B). This data suggests that SPD
facilitates the translocation of PKA catalytic subunits from the
cytosol to the nucleus.
4. Discussion
In this study we showed that H-89, an inhibitor of PKA, and
arcaine, an antagonist of the polyamine-binding site at the NMDA
receptor, prevent the facilitatory effect of SPD on the memory of an
inhibitory avoidance task. The injection of H-89 or arcaine also
prevented SPD-induced phosphorylation of PKA and CREB in the
hippocampus. While H-89 has been reported to inhibit protein
kinases other than PKA (Davies, Reddy, Caivano, & Cohen, 2000),
the currently reported reversal of known PKA-mediated responses,such as PKA and CREB phosphorylation by H-89, suggests that the
current effects of SPD on PKA and CREB phosphorylation as well as
their reversal by a PKA inhibitor (H-89) are not due to nonspeciﬁc
effects. The reversal of facilitatory effects of ih-injected SPD on
step-down inhibitory avoidance by a PKA inhibitor and a NMDA
receptor polyamine-binding site antagonist implicate the NMDA
receptor and PKA activation in SPD-induced facilitation of memory
(Figs. 1 and 4, respectively). This ﬁnding was corroborated by the
demonstration that SPD activates PKA, and that H-89 prevents
SPD-induced PKA activation (Fig. 2). SPD-induced activation of
PKA occurred 180 min after the injection of the polyamine, which
likely reﬂects the PKA activity peak 3–6 h after training. Further-
more, this peak correlates with the maximum rise in cAMP levels
after training (Bernabeu et al., 1997a). In agreement with this view,
Fig. 6. Effect of the post-training intrahippocampal co-administration of arcaine
(ARC, 0.02 nmol) and spermidine (SPD, 0.2 nmol) on representative images of
Western immunoblotting and densitometry analyses of phospho-CREB (A), total-
CREB (B), and the ratio of phospho-CREB/total-CREB (C) 180 min after the injection
of SPD and ARC. The results were normalized by arbitrarily setting the densitometry
of the control group (PBS/PBS). Ponceau staining served as a loading control. Data
are the mean ± SEM for four animals in each group. ⁄P < 0.05 as compared with
control group values (PBS/PBS).
Fig. 7. Effect of the post-training intrahippocampal administration of spermidine
(SPD, 0.2 nmol) on representative images of Western immunoblotting and densi-
tometry analyses of the cytosolic (A) and nuclear (B) fractions of phospho-PKA
catalytic subunits 180 min after the injection of SPD. The results were normalized
by arbitrarily setting the densitometry of the control group (PBS/PBS). Ponceau
staining served as a loading control. Data are the mean ± SEM for eight animals in
each group. ⁄P < 0.05 as compared with control group values.
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lation, supporting the involvement of NMDA receptors in SPD-in-
duced PKA activation (Fig. 6).
Because CREB phosphorylation depends on PKA activity (Berna-
beu et al., 1997a; Gonzalez & Montminy, 1989), we extended our
investigation to phospho-CREB levels. The ih administration of
SPD increased CREB phosphorylation, and as expected, H-89 and
arcaine prevented SPD-induced CREB phosphorylation (Figs. 3
and 6, respectively). In addition, SPD injection increased catalytic
phospho-PKA immunoreactivity in the nuclear fraction of the hip-
pocampus (Fig. 7). Because the hippocampal cAMP/PKA pathway is
activated by NMDA receptor-mediated Ca2+ inﬂux (Chetkovich
et al., 1991), it is very possible that Ca2+ inﬂux sequentially stimu-
lates adenylate cyclase (AC) activity, cAMP accumulation, and PKAand CREB phosphorylation (Eliot et al., 1989; Poser & Storm, 2001).
Indeed, it has been shown that cAMP binds to R PKA subunits,
resulting in the release of the monomeric C active subunit of PKA
(Gibbs et al., 1992; Taylor et al., 1990; Wang, Salter, & MacDonald,
1991;Wang et al., 2004). The free PKA C subunits translocate to the
nucleus, where they phosphorylate CREB (Dash, Karl, Colicos, Pry-
wes, & Kandel, 1991; Impey et al., 1998; Mayford, Wang, Kandel, &
O’Dell, 1995b). Interestingly, ih administration of SPD increased
p-PKA/PKA ratio at 180 min, mainly due to a decrease in the total
levels of the R subunit of PKA (Fig. 2E and F). Accumulating
evidence suggests that the PKA R subunits are degraded by ubiqui-
tin–proteasome-mediated proteolysis in animal (Hegde, Goldberg,
& Schwartz, 1993) and human brain (Liang, Liu, Grundke-Iqbal,
Iqbal, & Gong, 2007). Furthermore, lactacystin, a speciﬁc protea-
some inhibitor, completely blocks the forskolin-induced down-
regulation of the R subunit in differentiated human neuroblastoma
SH-SY5Y cells (Boundy, Chen, & Nestler, 1998). It has been
suggested that PKA R (RIIa and RIIb) and C subunit (Cb) deﬁcits de-
crease enzyme activity, and consequently, memory impairment in
patients with Alzheimer’s disease (Liang et al., 2007). In contrast,
degradation of R subunits by the proteasome gives rise to an excess
of C subunits. In support of this view, inhibitory avoidance training
causes a 33% NMDA receptor-dependent increase in the amount of
C subunits of PKA in nuclear fractions of hippocampal neurons
(Cammarota et al., 2000) and the ih injection of a proteasome
inhibitor blocks long-term memory (LTM) formation (Lopez-Salon
G.P. Guerra et al. / Neurobiology of Learning and Memory 96 (2011) 324–332 331et al., 2001). Further, it is interesting to note that the time course of
the effect of proteasome inhibitors on LTM formation parallels
those observed with two different speciﬁc inhibitors of PKA deliv-
ered into the same brain region (Bernabeu et al., 1997a; Vianna
et al., 2000) and coincides with the period during which hippocam-
pal PKA activity is increased (Izquierdo & Medina, 1997).
In summary, this study showed that SPD-induced memory facil-
itation depends on a sequence of biochemical events in the rat hip-
pocampus which is triggered by NMDA receptor, followed by PKA/
CREB signaling activation.
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